Effect of Inhalation Therapy on Children's Fear and Anxiety Levels and Physiological Parameters
NCT ID: NCT06486610
Last Updated: 2025-08-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2024-05-01
2025-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Inhalation Treatment Distraction in Children
NCT06874491
The Effect of Watching Informative Animation on Fear and Anxiety in Children
NCT05861232
The Ventriloquist Puppet Method for Children Under The Inhaler Treatment
NCT06162598
Effects of Interactive Toys and Robots on Anxiety and Fear in Children Receiving Nebulized Inhalation in the Pediatric Emergency Department
NCT07056816
The Effect of an Undersea-Themed ECG Cover on Fear and Anxiety Levels in Children
NCT07201350
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Data Collection:
Data for the study will be obtained through face-to-face interviews. Initially, children in the groups using either a toy-figured nebulizer or a Sound-Insulated (Silent) Nebulizer will complete an Introductory Information Form. The physiological parameters of the children will be measured by an experienced nurse in pediatric emergency care 15 minutes before, during the 10th minute of, and 15 minutes after the nebulizer medication application, and recorded on a 'Physiological Parameters Form.' Additionally, the Child Fear Scale and the Emotional Indicators in Children Scale will be administered 15 minutes before, during the 10th minute of, and 15 minutes after the medication application with the toy-figured nebulizer. For the control group, routine inhalation therapy of the service will be applied without any additional intervention. Children in this group will also fill out the Introductory Information Form. Their life signs will be measured similarly by the experienced nurse and recorded on a 'Physical Parameters Form.' The Child Fear Scale and Emotional Indicators in Children Scale will be administered during the 10th minute and 15 minutes after the routine medication application. Due to the nature of the study, blinding during the execution will not be possible; however, to prevent potential bias, measurements will be taken by both the experienced nurse (for physiological parameters, Child Fear Scale, Emotional Indicators in Children Scale) and parents (for Child Fear Scale, Emotional Indicators in Children Scale). Statistical analysis and reporting will be conducted without knowledge of which group is the experimental or control group (coding will be applied).
Data Evaluation:
Data processing and statistical analyses will be performed using Statistical Package for the Social Sciences for Windows 20.0. For measurements not conforming to a normal distribution, non-parametric methods will be utilized. The Kruskal-Wallis H test (χ2-table value) will be used for comparing three or more independent groups. Pearson-χ2 cross-tabulations will be employed to examine the relationships between two qualitative variables. The Spearman correlation coefficient will be used to analyze the relationships between two quantitative variables that do not follow a normal distribution.
Ethical Principles of the Research:
For the execution of the study, official permission has been obtained from the Ethical Committee of the Recep Tayyip Erdogan University Faculty of Medicine. Children eligible for the research group, along with their parents, will be informed about the purpose of the study, and their questions will be answered before obtaining their verbal and written consent. Parents and children will be assured that the data collected during the research will be processed anonymously and confidentially, will not be used outside of this study, and they may withdraw from the study at any time.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group: Routine clinical practice
Fear, Emotional Indicators and Physiological Parameters in Children
No interventions assigned to this group
Therapeutic play: Fish-shaped nebulizer and fish-shaped toy
Fear, Emotional Indicators and Physiological Parameters in Children
Fish-shaped nebulizer and fish-shaped toy
In order to reduce the child's fear and anxiety, it is planned to apply inhalation therapy using a nebulizer with a red fish figure and an amigurumi toy with a red fish figure.
silent nebulizer
Fear, Emotional Indicators and Physiological Parameters in Children
Silent nebulizer
It is planned to apply inhalation therapy using a silent nebulizer to reduce the child's fear and anxiety.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fish-shaped nebulizer and fish-shaped toy
In order to reduce the child's fear and anxiety, it is planned to apply inhalation therapy using a nebulizer with a red fish figure and an amigurumi toy with a red fish figure.
Silent nebulizer
It is planned to apply inhalation therapy using a silent nebulizer to reduce the child's fear and anxiety.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Nebulizer and inhaler treatment will be applied
* The child does not have a mental or neurological disability
* Applying due to respiratory system disease
* The presence of the child's mother during the application period
* Mother and child can speak Turkish
* The mother does not have any obstacle to communication
* Mother's literacy
* Parent and child volunteering to participate in the research.
Exclusion Criteria
* The child is hyperthermic (body temperature is 38 C and above)
* The child has pain,
* The child is in the terminal period,
* The parent has a condition that prevents him/her from evaluating the scale (mental disability, etc.).
3 Years
6 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Recep Tayyip Erdogan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mehtap METİN KARAASLAN
Study Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mehtap METİN KARAASLAN
Role: STUDY_DIRECTOR
Recep Tayyip Erdogan Universİty
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Recep Tayyip Erdoğan University Faculty of Health Sciences
Rize, Güneysu, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1528/TSA-2023-1528
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.